tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Ownership - Who Owns Supernus Pharmaceuticals?

Compare
501 Followers

Supernus Pharmaceuticals (SUPN) Ownership Overview

4.12%31.78%28.93%31.61%3.55%
28.93% Other Institutional Investors
31.61% ETFs
3.55% Public Companies and
Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 92.33% of the company’s stock is owned by Institutional Investors, 4.12% is owned by Insiders, and 3.55% is owned by Public Companies and Individual Investors.
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 60.71% of the company’s stock is owned by Institutional Investors, 4.12% is owned by Insiders, and 31.61% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 05, 2025
Padmanabh Bhatt
Sr. Vp Of Ip, Cso
xxxxxxxxxxxxx
$376237
Jan 29, 2025
Padmanabh Bhatt
Sr. Vp Of Ip, Cso
xxxxxxxxxxxxx
$129676
Dec 04, 2024
Padmanabh Bhatt
Sr. Vp Of Ip, Cso
xxxxxxxxxxxxx
$788437
Nov 12, 2024
Jack Khattar
Director
xxxxxxxxxxxxx
$4536250

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,398,260Institution11.46%200,009,608
5,479,516Institution9.82%171,289,670
4,713,026Institution8.44%147,329,193
2,014,283Insider3.61%62,966,487
1,995,690Institution3.58%62,385,269
1,699,603Institution3.05%53,129,590
1,279,524Institution2.29%39,997,920
1,050,222Institution1.88%32,829,940
1,010,760Institution1.81%31,596,358
991,160Institution1.78%30,983,662

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,713,026Institution8.44%147,329,193
1,995,690Institution3.58%62,385,269
1,699,603Institution3.05%53,129,590
1,050,222Institution1.88%32,829,940
650,148Institution1.16%20,323,626
569,059Institution1.02%17,788,784
548,772Institution0.98%17,154,613
446,766Institution0.80%13,965,905
388,935Institution0.70%12,158,108
358,847Institution0.64%11,217,557

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,501,896Institution6.27%109,469,269
1,664,441Institution2.98%53,361,978
1,358,323Institution2.43%42,461,177
1,335,837Institution2.39%48,303,866
1,271,434Institution2.28%39,630,598
883,404Institution1.58%27,615,209
881,336Institution1.58%28,255,632
834,080Institution1.49%26,740,605
491,900Institution0.88%15,332,523
428,791Institution0.77%13,404,007

FAQ

Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 28.93% of the company's stock is held by institutional investors, 4.12% is held by insiders, and 3.55% is held by retail investors.
    What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 28.93% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
      What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 3.55% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
        Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
        iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis